QUICKHEAL: Q2 FY27 returned to positive EBITDA and PAT as enterprise demand and execution priorities advanced

What happened

Quick Heal reported Q2 FY27 revenue of ₹64.9 Cr. Earnings before interest, taxes, depreciation and amortization (EBITDA) and profit after tax (PAT) both turned positive after losses in Q1. Enterprise order visibility exceeded ₹57 Cr, and priorities include tighter execution, collections and innovation.

Confirmed

Global impact / market context

Returning to positive EBITDA, which means operating profit before certain costs, and positive PAT, or final profit, suggests the company is covering its running costs again. Order visibility above ₹57 Cr points to future revenue potential, though converting orders into cash depends on execution and collections.

Analyst inference

The shift from Q1 losses to Q2 profit shows a sequential recovery within the same financial year. Investors may focus on whether enterprise demand converts into recorded revenue and cash collection, since order visibility alone does not guarantee sales or cash inflow.

Analyst inference

What to watch

1. The company's stated priorities are tighter execution, collections and innovation, so progress on converting the ₹57 Cr-plus enterprise order visibility into revenue and cash will be a key item to track. Confirmed
2. Management could be asked whether the return to positive EBITDA and PAT is expected to continue in coming quarters, and what specific execution changes support that expectation. Proposed
3. If collections improve, cash available to the business should rise, supporting operations without extra borrowed money. If execution slips, order visibility may not translate into revenue or profit. Analyst inference

Evidence

• Original source link unavailable